Consolidated Statements of Stockholders’ Equity - USD ($)	Convertible Preferred Stock	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021		$ 265	$ 138,740,827	$ (116,493,530)	$ 22,247,562
Balance (in Shares) at Dec. 31, 2021		26,487,680
Exercise of stock options		$ 7	114,162		114,169
Exercise of stock options (in Shares)		717,041
Issuance of common stock in connection with issued RSUs
Issuance of common stock in connection with issued RSUs (in Shares)		28,530
Issuance of common stock and pre-funded warrants in connection with the private placement offering, net of offering costs of $1,857,700		$ 38	11,989,471		11,989,509
Issuance of common stock and pre-funded warrants in connection with the private placement offering, net of offering costs of $1,857,700 (in Shares)		3,790,322
Issuance of common stock upon exercise of pre-funded warrants		$ 27	2,635		2,662
Issuance of common stock upon exercise of pre-funded warrants (in Shares)		2,661,291
Issuance of common warrants at fair value in connection with the private placement			6,132,436		6,132,436
Stock-based compensation			2,867,698		2,867,698
Net loss				(19,236,509)	(19,236,509)
Balance at Dec. 31, 2022		$ 337	159,847,229	(135,730,039)	24,117,527
Balance (in Shares) at Dec. 31, 2022		33,684,864
Exercise of stock options		$ 2	8,526		8,528
Exercise of stock options (in Shares)		172,492
Issuance of common stock and pre-funded warrants in connection with the public offering, net of offering costs of $618,965		$ 230	4,380,745		4,380,975
Issuance of common stock and pre-funded warrants in connection with the public offering, net of offering costs of $618,965 (in Shares)		22,966,733
Issuance of common stock at-the-market equity financing, net of offering costs of $97,362		$ 37	1,747,431		1,747,468
Issuance of common stock at-the-market equity financing, net of offering costs of $97,362 (in Shares)		3,731,524
Stock dividend, net of offering costs of $16,182		$ 42	1,460,126	(1,476,350)	$ (16,182)
Stock dividend, net of offering costs of $16,182 (in Shares)		4,218,143
Exercise of stock options (in Shares)					25,750
Issuance of common stock and pre-funded warrants in connection with the private placement offering, net of offering costs of $1,857,700 (in Shares)					3,790,322
Stock-based compensation			3,208,103		$ 3,208,103
Net loss				(22,811,230)	(22,811,230)
Balance at Dec. 31, 2023		$ 648	$ 170,652,160	$ (160,017,619)	$ 10,635,189
Balance (in Shares) at Dec. 31, 2023		64,773,756